- Reuben Guttman: The lawyer pharma loves to hate (statnews.com)
Reuben Guttman wants us all to be concerned about what’s in our medicine cabinets. A Washington lawyer who specializes in prosecuting pharmaceutical fraud, Guttman has gone after Pfizer, Abbott, GlaxoSmithKline, and several other top drug makers — and he usually wins big, recouping billions of dollars for federal and state governments...STAT talked with Guttman about bad behavior in the drug industry, and whom he trusts for his own medical care.
- The lawsuits you’ve won often center on unlawful marketing and kickback schemes. How widespread are these practices?
- How does your work as a lawyer impact the health care system?
- And the consequence for patients?
- Is there anything patients can do to protect themselves?
- Knowing what you know, do you avoid doctors and hospitals?
- What’s the next big pharma scam?
- What do you do in your spare time?
- Are you an athlete yourself?
- When you were a kid, did you fantasize about being a whistleblower attorney?
- 2015: The Health Care Year in Review (commonwealthfund.org)
When it comes to historic changes in the U.S. health care system, few years could compete with 2014, but 2015 gave it a run for its money. With 2016 knocking at the door, it’s time to take a look back and round up the biggest health care events of the year.
- The health spending slowdown ends.
- Rx pricing lands in the spotlight.
- The insurance expansion presses on…
- …But the pay-fors take a hit.
- Consolidation reshapes the health care landscape.
- Collapse of the CO-OPs.
- Health care politics mellowing?
- Rates of hospital-acquired conditions remain low.
- Mortality is rising for white, middle-aged Americans.
Despite the year’s ups and downs, it’s clear that the insurance expansions continued to make a big impact in the lives of Americans in 2015. Here’s to a new year in which we continue to make coverage gains—and make inroads on issues such as drugs spending and broader economic inequality.
- Pharmacists ranked No. 2 in latest Gallup ethics poll (drugstorenews.com)Americans Rate Nurses Highest on Honesty, Ethical Standards (gallup.com)
Pharmacists ranked No. 2 in Gallup's 2015 Honesty and Ethics of Professions Ratings, falling behind No. 1 ranked nurses and ahead of No. 3 ranked medical doctors...This annual Gallup survey presents another data point in the strong and growing case for pharmacy patient care...those who have more first-hand experience with pharmacist-provided services feel even more strongly about their value. These positive attitudes are translating into ever-stronger bipartisan support for pro-patient and pro-pharmacy initiatives in the U.S. Congress, as well as an expansion of the pharmacists’ scope of practice in the states.
- CMS demands scrutiny of opioids, antipsychotics in Medicaid (modernhealthcare.com)2016 Updates to the Child and Adult Core Health Care Quality Measurement Sets (medicaid.gov)
CMS plans to more closely track the use of opioids by adults and antipsychotics among children and adolescents with new quality measures for Medicaid and the Children's Health Insurance Program...The agency issued a notice this month outlining the new measures, which come amid a national epidemic of opioid abuse and a rising unease with the high rates of antipsychotic medications prescribed to minors for off-label uses...CMS will require Medicaid programs...to track the use of opioids at high dosages acquired from four or more providers and pharmacies by beneficiaries who don't have cancer...The measure is intended to indicate inappropriate prescribing or fragmented care...American Pharmacists Association said the new Medicaid measure could help identify patterns of opioid misuse...The CHIP measure, meanwhile, would track the percentage of children and adolescents who are on two or more antipsychotic medications at the same time...an analysis by HHS' Office of Inspector General found that 92% of antipsychotics taken by Medicaid children in five states were prescribed for off-label uses...The use of multiple antipsychotic medications “is seldom justified and is an appropriate focus for a quality measure,”...children on Medicaid are prescribed antipsychotics at much higher rates than privately insured children.
- Chinese medicinal herbs provide niche market for US farmers (hosted.ap.org)
Expanding interest in traditional Chinese medicine in the United States is fostering a potentially lucrative new niche market for farmers who plant the varieties of herbs, flowers and trees sought by practitioners...While almost all practitioners still rely on imports from China, dwindling wild stands there, as well as quality and safety concerns, could drive up demand for herbs grown in the U.S. Several states have set up "growing groups" to help farmers establish trial stands of the most popular plants....Traditional Chinese medicine is gaining mainstream acceptance in the U.S. There are 30,000 licensed practitioners across the country - 46 states issue licenses, often requiring a master's degree and continuing education credits. In 2014, the Cleveland Clinic opened one of the first hospital-based Chinese herbal therapy clinics in the country...If growers in the U.S. can produce a highest-quality product that is identical to species from China, without contamination from heavy metals or pesticides, I think it's a great opportunity for farmers...
- How Closer Integration of Pharmacists into Care Teams Improves Outcomes (pharmacytimes.com)
Alexander Kantorovich, PharmD, BCPS, clinical assistant professor of pharmacy practice at Chicago State University College of Pharmacy, discusses how closer integration of pharmacists into care teams improves outcomes for patients taking new oral anticoagulants.
- Pharmacy delivery vans targeted by thieves seeking painkillers (statnews.com)
They’re the new Brink’s trucks...Delivery vans that transport prescription painkillers from warehouses to pharmacies and hospitals are the targets of an escalating number of thefts across the country...Amid a nationwide epidemic of opioid addiction, the delivery vans have become an appealing and vulnerable target for thieves, addicts, and drug dealers...Hitting the right pharmaceutical courier can yield a payoff similar to robbing an armored car. But the pharmaceutical van drivers usually receive little security training, work alone, and rarely carry weapons...“We still have a segment of criminals that very much want to get their hands on those pills because they have high street value,”...“People are willing to go to extreme means to get those pills.”...Three wholesalers, with combined revenues of over $300 billion, dominate the US pharmaceutical market. All three declined to answer specific questions about how often couriers delivering their products are robbed, any security measures undertaken in recent years, and their reliance on independent contract drivers to deliver their goods...Cardinal Health said the company maintains “robust safety measures to ensure the safe distribution of products.”...McKesson Corporation said it would not answer questions for “security reasons.” AmerisourceBergen...did not provide responses to questions.
- Managed Care Pharmacy Resident Q&A (pharmacytimes.com)Have you ever wondered what opportunities exist for pharmacists in managed care organizations?...To find out, I spoke with Alex Wiggall, PharmD, a managed care pharmacy resident at Horizon Blue Cross Blue Shield of New Jersey in Newark...Dr. Wiggall grew up in the Philadelphia area before graduating with his Doctor of Pharmacy degree from University of Maryland School of Pharmacy. After completing his residency, he hopes to find a job at a health plan in the New York City area.
- Why did you decide to pursue a managed care residency?
- What is the structure of your residency?
- What are your day-to-day tasks?
- How did you decide that your residency program was the right fit for you?
- What career opportunities does a pharmacy resident have after completing a managed care program?
- What advice do you have for students looking to pursue a residency in managed care?
- Pharmacy Week in Review: December 23, 2015 (pharmacytimes.com)
Mike Glaicar, Business Development: Pharmacy Times...(PTNN) This weekly video program highlights the latest in pharmacy news, product news, and more. (video)
- 3 people to watch in biotech and drug pricing in 2016 (statnews.com)
Big valuations, big investments, and big price tags drove lots of the news in health care in 2015 — and you can bet they’ll do the same in the new year. For signs of where things are headed, keep an eye on these three influencers:
- Jeffrey Marrazzo, chief executive of Spark Therapeutics - Can gene therapy work — and can the system afford to pay for it?...The idea that a one-time treatment could replace a broken gene has generated plenty of scientific and commercial interest.
- Deborah DiSanzo, general manager of Watson Health - IBM’s big bet on health care analytics...use high-powered computing to sift through massive amounts of data to find useful and cost-saving nuggets for medical researchers, doctors, and insurers.
- Vivek Ramaswamy, chief executive of Axovant Sciences - has recruited some top Alzheimer’s researchers to join his...company...they initiated a late-stage clinical trial testing the GSK reject in combination with another Alzheimer’s drug.







